Brief: Harvard Bioscience Granted 180 Days For Compliance - SEC Filing
03/10/2025 14:26
Oct 3 (Reuters) - SEC Filing: HARVARD BIOSCIENCE INC - GRANTED 180 DAYS OR UNTIL MARCH 30, 2026 BY NASDAQ FOR COMPLIANCE - SEC FILING Source text: [ID:n0001171843-25-006260] Further company coverage: HBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance